T-cell Receptor (TCR) Usage in Lewis Rat Experimental Autoimmune Encephalomyelitis: TCR Beta-chain-variable-region V Beta 8.2-positive T Cells Are Not Essential for Induction and Course of Disease
Overview
Authors
Affiliations
Predominant usage of V beta 8.2 gene segments, encoding a T-cell receptor (TCR) beta chain variable region, has been reported for pathogenic Lewis rat T cells reactive to myelin basic protein (MBP). However, up to 75% of the alpha/beta T cells in a panel of MBP-specific T-cell lines did not display TCR V beta 8.2, V beta 8.5, V beta 10, or V beta 16 elements. To further investigate TCR usage, we sorted the T-cell lines for V beta 8.2- and V beta 10-positive T cells or depleted the lines of cells with these TCRs. V beta 8.2-positive T cells and one of the depleted T-cell lines strongly reacted against the MBP peptide MBP-(68-88). The depleted T-cell line caused marked experimental autoimmune encephalomyelitis (EAE) even in Lewis rats in which endogenous V beta 8.2-positive T cells had been eliminated by neonatal treatment with anti-V beta 8.2 monoclonal antibodies. T-cell hybridomas generated from this line predominantly used V beta 3 TCR genes coexpressed with TCR V alpha 2 transcripts, which were also used by V beta 8.2-positive T cells. Furthermore, V beta 10-positive T cells reactive to MBP-(44-67) were encephalitogenic when injected immediately after positive selection. After induction of EAE by sorted V beta 8.2- or V beta 10-positive T-cell lines, immunocytochemical analysis of the spinal cord tissue showed a predominance of the injected TCR or of nontypable alpha/beta T cells after injection of the depleted line. Our results demonstrate heterogeneity of TCR beta-chain usage even for a single autoantigen in an inbred strain. Moreover, V beta 8.2-positive T cells are not essential for the induction and progression of adoptive-transfer EAE.
Nanoparticle transport across the blood brain barrier.
Grabrucker A, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli M Tissue Barriers. 2016; 4(1):e1153568.
PMID: 27141426 PMC: 4836460. DOI: 10.1080/21688370.2016.1153568.
Wust S, Tischner D, John M, Tuckermann J, Menzfeld C, Hanisch U PLoS One. 2009; 4(12):e8202.
PMID: 19997594 PMC: 2781169. DOI: 10.1371/journal.pone.0008202.
Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction.
Boettger M, Weishaupt A, Geis C, Toyka K, Sommer C J Neural Transm (Vienna). 2009; 117(2):165-9.
PMID: 19946712 DOI: 10.1007/s00702-009-0342-6.
Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka K, Lin C J Exp Med. 2005; 202(3):445-55.
PMID: 16061730 PMC: 2213080. DOI: 10.1084/jem.20051060.
Weilbach F, Chan A, Toyka K, Gold R Clin Exp Immunol. 2003; 135(1):49-55.
PMID: 14678264 PMC: 1808927. DOI: 10.1111/j.1365-2249.2004.02344.x.